Emily Couric Clinical Cancer Center is a clinical research site located in Charlottesville, Virginia, United States 22903.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Emily Couric Clinical Cancer Center has participated in 13 clinical trials with 2 currently active.
Therapeutic areas: Metastatic Breast Cancer, B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma.
Sponsors: Pfizer, ADC Therapeutics S.A., Roswell Park Cancer Institute.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Emily Couric Clinical Cancer Center has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Emily Couric Clinical Cancer Center has 13 clinical trials on record, with 2 currently active. Their work covers Metastatic Breast Cancer, B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma.
Yes — Emily Couric Clinical Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.